Mersana Therapeutics, Inc.
MRSN
$7.68
$0.0250.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.72% | -70.88% | -22.75% | 52.61% | -25.70% |
| Total Depreciation and Amortization | -9.18% | -21.00% | -0.50% | -0.25% | -4.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.14% | -2.82% | -7.78% | -0.73% | -8.44% |
| Change in Net Operating Assets | 77.21% | 1.28% | -538.43% | 27.32% | 89.08% |
| Cash from Operations | 22.93% | -52.33% | -124.45% | 60.75% | 33.08% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -46.00% | 75.62% | 416.32% | 107.61% |
| Cash from Investing | -98.54% | -46.00% | 75.62% | 416.32% | 107.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -49.74% | -9,008.70% | 51.06% | 27.69% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -96.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.92% | -68.02% | -8,017.39% | -115.03% | -97.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -363.39% | -118.91% | 45.35% | 222.75% | 83.71% |